Prospects in GSK-3 Signaling: From Cellular Regulation to Disease Therapy
Cells
; 11(10):1618, 2022.
Article
in English
| ProQuest Central | ID: covidwho-1871689
ABSTRACT
[...]the incorrect regulation of these pathways as a result of GSK-3 hyperactivity impairs normal cellular homeostasis. [...]disruptions to the normal niche function, reflected by GSK-3 hyperactivity, may be used as a diagnostic tool to detect aberrant activity of stem cells [5]. [...]the absence of GSK-3 improved glucose tolerance (GTT) in insulin-resistant animals fed a high-fat diet (HFD), but did not affect their body weight. [...]maintaining a healthy weight is of prime importance for patients on chronic lithium therapy [10].
Search on Google
Collection:
Databases of international organizations
Database:
ProQuest Central
Language:
English
Journal:
Cells
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS